What is the recommended dilution and concentration for a nicardipine intravenous infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nicardipine Infusion Dilution and Concentration

Nicardipine for intravenous infusion should be diluted to a concentration of 0.1 mg/mL (100 µg/mL) for standard administration, or 0.2 mg/mL (200 µg/mL) for premixed flexible containers. 1

Standard Preparation from Single-Dose Vials

Each 25 mg vial must be diluted with 240 mL of compatible IV fluid to yield 250 mL at a concentration of 0.1 mg/mL (100 µg/mL). 1 This is the FDA-approved standard concentration for nicardipine infusion.

Compatible Diluents

The following solutions are compatible for 24 hours at room temperature 1:

  • Dextrose 5% Injection
  • Dextrose 5% and Sodium Chloride 0.45% Injection
  • Dextrose 5% and Sodium Chloride 0.9% Injection
  • Dextrose 5% with 40 mEq Potassium
  • Sodium Chloride 0.45% Injection
  • Sodium Chloride 0.9% Injection

Do NOT use Sodium Bicarbonate 5% or Lactated Ringer's—these are incompatible with nicardipine. 1

Premixed Flexible Containers

Premixed nicardipine solutions come in two concentrations 1:

  • 20 mg in 200 mL (0.1 mg/mL)
  • 40 mg in 200 mL (0.2 mg/mL)

These require no dilution and are ready to use. 1

Clinical Context: Concentration and Phlebitis Risk

While the FDA-approved concentration is 0.1 mg/mL, research demonstrates that maintaining maximum nicardipine concentration below 130 µg/mL (0.13 mg/mL) significantly reduces phlebitis risk 2. In a study of 300 acute stroke patients, diluting nicardipine to concentrations below 130 µg/mL reduced phlebitis incidence from 30% to 9.9% (P < 0.001) 2.

This creates a practical consideration: the standard 0.1 mg/mL concentration is close to but below this threshold, while the 0.2 mg/mL premixed concentration exceeds it. For peripheral administration, the 0.1 mg/mL concentration is preferable to minimize phlebitis risk.

Administration Guidelines

Administer via central line or large peripheral vein. 1 If using peripheral access:

  • Change infusion site every 12 hours to reduce venous irritation 1, 3, 4
  • Avoid small veins (dorsum of hand or wrist) 5
  • Monitor for signs of phlebitis

Do not combine nicardipine with any other product in the same IV line or premixed container. 1

Dosing Reference (for context, not dilution)

The guidelines consistently recommend 3, 4, 3, 6, 7:

  • Initial rate: 5 mg/hr
  • Titrate by 2.5 mg/hr every 5-15 minutes
  • Maximum: 15 mg/hr
  • Once target BP achieved, reduce to 3 mg/hr for maintenance 4

References

Research

Reduction of Nicardipine-Related Phlebitis in Patients with Acute Stroke by Diluting Its Concentration.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.